Toyota|$17.22 (¥2,777)-0.61%▼ (in JPY terms)
Sony|$19.47 (¥3,140)-3.38%▼ (in JPY terms)
SoftBank|$44.09 (¥7,111)-1.08%▼ (in JPY terms)
MUFG|$20.32 (¥3,278)-2.85%▼ (in JPY terms)
Keyence|$481.77 (¥77,700)+0.23%▲ (in JPY terms)
Nintendo|$43.87 (¥7,076)-1.26%▼ (in JPY terms)
NTT|$0.90 (¥144)-2.37%▼ (in JPY terms)
Takeda|$30.59 (¥4,934)-2.04%▼ (in JPY terms)
Tokyo Electron|$467.26 (¥75,360)-0.95%▼ (in JPY terms)
Recruit|$67.37 (¥10,865)-2.69%▼ (in JPY terms)
ITOCHU|$11.46 (¥1,848)-1.26%▼ (in JPY terms)
Honda|$8.76 (¥1,413)-0.11%▼ (in JPY terms)
Shin-Etsu|$45.32 (¥7,310)-2.00%▼ (in JPY terms)
Tokio Marine|$44.61 (¥7,194)-1.77%▼ (in JPY terms)
Fast Retailing|$515.25 (¥83,100)-1.19%▼ (in JPY terms)
Toyota|$17.22 (¥2,777)-0.61%▼ (in JPY terms)
Sony|$19.47 (¥3,140)-3.38%▼ (in JPY terms)
SoftBank|$44.09 (¥7,111)-1.08%▼ (in JPY terms)
MUFG|$20.32 (¥3,278)-2.85%▼ (in JPY terms)
Keyence|$481.77 (¥77,700)+0.23%▲ (in JPY terms)
Nintendo|$43.87 (¥7,076)-1.26%▼ (in JPY terms)
NTT|$0.90 (¥144)-2.37%▼ (in JPY terms)
Takeda|$30.59 (¥4,934)-2.04%▼ (in JPY terms)
Tokyo Electron|$467.26 (¥75,360)-0.95%▼ (in JPY terms)
Recruit|$67.37 (¥10,865)-2.69%▼ (in JPY terms)
ITOCHU|$11.46 (¥1,848)-1.26%▼ (in JPY terms)
Honda|$8.76 (¥1,413)-0.11%▼ (in JPY terms)
Shin-Etsu|$45.32 (¥7,310)-2.00%▼ (in JPY terms)
Tokio Marine|$44.61 (¥7,194)-1.77%▼ (in JPY terms)
Fast Retailing|$515.25 (¥83,100)-1.19%▼ (in JPY terms)

FUJIFILM Holdings Corporation (4901)

TSE 4901 · Chemicals

FUJIFILM Holdings Corporation

富士フイルムホールディングス株式会社
$20.98 (¥3,383)
-56.0 (-1.63%)in JPY terms
Delayed quote · Yahoo Finance
🏢 Industry: Chemicals
🌐 ISIN: JP3814000000
📊 TSE: 4901
Company Overview

FUJIFILM Holdings has successfully transformed from a photographic film company into a diversified technology group with major businesses in healthcare, materials science, and document solutions. Today its operations include diagnostic imaging systems, biopharmaceutical contract manufacturing, regenerative medicine, and advanced functional materials used in semiconductor fabrication and displays.

For international investors, FUJIFILM is a compelling case study in corporate transformation, having leveraged its core expertise in precision chemistry to build leadership positions in high-growth industries. The company's healthcare segment, which includes medical imaging and pharmaceutical manufacturing services, is a significant growth engine with global reach, while its materials division benefits from expanding demand in advanced electronics production.

Recent Press Releases
2026-06-172026-06-16 FUJIFILM Holdings Corporation “Fujifilm has jointly developed an "in-line Raman high-sensitivity measurement system" that visualizes the culture and purification processes in biopharmaceutical manufacturing in real time.”2026-06-162026-06-15 FUJIFILM Holdings Corporation “Fujifilm received the 2026 Japan Society of Photographic Sciences "Technical Award" for the development of the integrated lens digital camera "FUJIFILM GFX100RF".”2026-06-112026-06-10 FUJIFILM Holdings Corporation “Fujifilm Business Innovation opens "Revoria Experience Center" in India, a new base for verifying and training personnel in high-value-added printing.”2026-06-092026-06-08 FUJIFILM Holdings Corporation “Fujifilm launches new pressure measurement film "Circular Prescale".”2026-05-212026-05-20 FUJIFILM Holdings Corporation “Fujifilm opens new headquarters in Wisconsin, USA.”2026-05-202026-05-19 FUJIFILM Holdings Corporation “By utilizing AI generation, data entry tasks for non-standard forms are streamlined (Fujifilm Business Innovation).”2026-05-202026-05-19 FUJIFILM Holdings Corporation “"Tunnel Inspection DX Solution" now supports railway tunnel inspection (Fujifilm).”2026-05-192026-05-18 FUJIFILM Holdings Corporation “The FUJIFILM GFX100RF, a digital camera with an integrated lens, won the "Best of the Best Award."”2026-05-132026-05-12 FUJIFILM Holdings Corporation “Announcement Regarding the Selection of Candidates for the Board of Directors of Fujifilm Holdings.”2026-05-092026-05-08 FUJIFILM Holdings Corporation “Fujifilm has obtained manufacturing and marketing approval for "Seibicus® Injection," the first regenerative medicine product in Japan for treating meniscus injuries.”
Key Data
52W High
$23.48 (¥3,787)
52W Low
$17.70 (¥2,855)
TSE Code
4901
ISIN
JP3814000000